These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8686329)

  • 21. [Patient with heart failure. Beta blockage becomes mandatory].
    Einecke D
    MMW Fortschr Med; 2000 Sep; 142(36):14-6. PubMed ID: 11021061
    [No Abstract]   [Full Text] [Related]  

  • 22. Carvedilol outclasses the other beta-blockers.
    Cardiovasc J S Afr; 2001; 12(2):120-1. PubMed ID: 11474696
    [No Abstract]   [Full Text] [Related]  

  • 23. Pre-discharge initiation of beta-blocker therapy in elderly patients hospitalized for acute decompensation of chronic heart failure: an effective strategy for the implementation of beta-blockade in heart failure.
    Tarantini L; Cioffi G; Opasich C; Di Lenarda A; Pulignano G; Del Sindaco D; De Feo S; Stefenelli C; Russo P; Catania G
    Ital Heart J; 2004 Jun; 5(6):441-9. PubMed ID: 15320569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Do standardized beta-blocker titration protocols in heart failure improve compliance? The GESICA registry experience.
    Remme WJ
    Cardiovasc Drugs Ther; 2005 Mar; 19(2):99-101. PubMed ID: 16025226
    [No Abstract]   [Full Text] [Related]  

  • 25. Carvedilol: a countermeasure to heart failure.
    Barkman A; Pooler C
    Dimens Crit Care Nurs; 2001; 20(5):11-6. PubMed ID: 22076514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A case of severe diabetes mellitus occurred during management of heart failure with carvedilol and furosemide.
    Kobayakawa N; Sawaki D; Otani Y; Sekita G; Fukushima K; Takeuchi H; Aoyagi T
    Cardiovasc Drugs Ther; 2003 May; 17(3):295. PubMed ID: 14669748
    [No Abstract]   [Full Text] [Related]  

  • 27. [Carvedilol and heart failure: new findings].
    Cosín Aguilar J
    Rev Esp Cardiol; 1996 Feb; 49(2):85-7. PubMed ID: 8948716
    [No Abstract]   [Full Text] [Related]  

  • 28. Beta-blockade in heart failure: a potential role.
    Kwasniewski R; Clem J
    S D J Med; 1997 Jan; 50(1):25-6. PubMed ID: 9029989
    [No Abstract]   [Full Text] [Related]  

  • 29. COMET: a proposed mechanism of action to explain the results and concerns about dose.
    Coca SG; Buller GK
    Lancet; 2003 Sep; 362(9389):1076; author reply 1077-8. PubMed ID: 14522541
    [No Abstract]   [Full Text] [Related]  

  • 30. [Carvedilol in cardiac decompensation].
    Dib J
    Rev Med Liege; 1996 Feb; 51(2):198-200. PubMed ID: 8650455
    [No Abstract]   [Full Text] [Related]  

  • 31. Which beta-blocker for heart failure?
    Patel MR; Gattis W
    Am Heart J; 2004 Feb; 147(2):238. PubMed ID: 14760319
    [No Abstract]   [Full Text] [Related]  

  • 32. Carvedilol.
    Frishman WH
    Indian Heart J; 1999; 51(3):325-32. PubMed ID: 10624077
    [No Abstract]   [Full Text] [Related]  

  • 33. Safety and efficacy of carvedilol in very elderly diabetic patients with heart failure.
    Del Sindaco D; Pulignano G; Cioffi G; Tarantini L; Di Lenarda A; De Feo S; Opasich C; Minardi G; Giovannini E; Leggio F
    J Cardiovasc Med (Hagerstown); 2007 Sep; 8(9):675-82. PubMed ID: 17700396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of beta-blockade on mortality rates in patients with congestive heart failure.
    Goldstein S; Gottlieb SS
    J Card Fail; 2000 Jun; 6(2 Suppl 1):15-24. PubMed ID: 10908094
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The COMET study compares effect of two different beta-blockers in chronic heart failure. Carvedilol better than metoprolol].
    Swedberg K
    Lakartidningen; 2003 Sep; 100(37):2852-4. PubMed ID: 14558169
    [No Abstract]   [Full Text] [Related]  

  • 36. [Place of beta blockaders in the treatment of heart failure].
    Pornin M; Van Viet H
    Ann Cardiol Angeiol (Paris); 1998 Dec; 47(10):753-6. PubMed ID: 9922855
    [No Abstract]   [Full Text] [Related]  

  • 37. Beta-blocker therapy for heart failure outside the clinical trial setting: findings of a community-based registry.
    Franciosa JA; Massie BM; Lukas MA; Nelson JJ; Lottes S; Abraham WT; Fowler M; Gilbert EM; Greenberg B;
    Am Heart J; 2004 Oct; 148(4):718-26. PubMed ID: 15459606
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carvedilol for heart failure: more than just a beta-blocker?
    Cleland JG
    Br J Hosp Med; 1997 Nov 19-Dec 9; 58(10):493-7. PubMed ID: 10193451
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Betaxolol versus carvedilol in chronic heart failure (BETACAR study). Rationale and design.
    Böhler S; Saubadu S; Scheldewaert R; Figulla HR
    Arzneimittelforschung; 1999 Apr; 49(4):311-7. PubMed ID: 10337449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beta blocker treatment of heart failure patients with ongoing cocaine use.
    Littmann L; Narveson SY; Fesel NM; Marconi SL
    Int J Cardiol; 2013 Oct; 168(3):2919-20. PubMed ID: 23664043
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.